---
title: Qlosi Eye Drops for Presbyopia | Orasis Pharmaceuticals
description: Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% is an FDA-approved prescription eye drop for presbyopia in adults, available through BlinkRx.
image: https://orasis-pharma.com/hubfs/raw_assets/public/orasis-website/images/home-hero-bg.jpg
---
[Skip to content](https://orasis-pharma.com/qlosi#main-content)
[ ](https://orasis-pharma.com?hsLang=en)
- [ About ](https://orasis-pharma.com/about?hsLang=en)
#### [Company Overview Our mission, vision, and story](https://orasis-pharma.com/about?hsLang=en)
#### [Leadership Team Meet the executives driving our vision](https://orasis-pharma.com/leadership?hsLang=en)
#### [Board of Directors Guidance from industry leaders](https://orasis-pharma.com/board?hsLang=en)
#### [Investors Our partners in innovation](https://orasis-pharma.com/investors?hsLang=en)
- [ Qlosi ](https://orasis-pharma.com/qlosi?hsLang=en)
- [ Presbyopia ](https://orasis-pharma.com/presbyopia?hsLang=en)
- News
[Press Releases](https://orasis-pharma.com/press-releases?hsLang=en) [In the Media](https://orasis-pharma.com/in-the-media?hsLang=en)
- [Contact](https://orasis-pharma.com/contact?hsLang=en)
[Qlosi.com](https://qlosi.com?hsLang=en)
Available by Prescription in the U.S.
# Qlosi®
Now Available 
Qlosi® (pilocarpine HCl ophthalmic solution) 0.4% is indicated for the treatment of presbyopia in adults. Available by prescription through BlinkRx.
[Learn More](https://www.qlosi.com?hsLang=en)
### Qlosi® Important Safety Information
- Do not use Qlosi if you are allergic to any of the ingredients.
- Use caution when driving at night or performing hazardous activities in poor lighting. Qlosi may cause temporary dim or dark vision.
- Temporary problems when changing focus between near objects and distant objects may occur. Do not drive or operate machinery if your vision is not clear.
- Seek immediate medical care if you experience sudden onset of flashes of light, floaters or vision loss.
- If you wear contact lenses, they should be removed before using Qlosi. Wait 10 minutes after dosing before reinserting your contact lenses.
- Do not touch the tip of the vial to the eye or any other surface to prevent eye injury or contamination.
- If you use more than one eye medication, use each medication at least 5 minutes apart.
- The most common side effects reported with Qlosi in clinical trials were eye pain upon instillation and headache. These are not all of the possible side effects with Qlosi.
To report suspected side effects, contact Orasis Pharmaceuticals at 1-866-ORASIS-1 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Please see full Prescribing Information by [clicking here](https://orasis-pharma.com/qlosi#).
[ ](https://orasis-pharma.com/?hsLang=en)
An ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities.
#### Company
[Company Overview](https://orasis-pharma.com/about?hsLang=en) [Leadership Team](https://orasis-pharma.com/leadership?hsLang=en) [Board of Directors](https://orasis-pharma.com/board?hsLang=en) [Investors](https://orasis-pharma.com/investors?hsLang=en)
#### Product
[About Qlosi](https://orasis-pharma.com/qlosi?hsLang=en) [About Presbyopia](https://orasis-pharma.com/presbyopia?hsLang=en) [Qlosi.com](https://qlosi.com?hsLang=en)
#### News & Contact
[Press Releases](https://orasis-pharma.com/press-releases?hsLang=en) [In the Media](https://orasis-pharma.com/in-the-media?hsLang=en) [Contact Us](https://orasis-pharma.com/contact?hsLang=en) [info@orasis-pharma.com](mailto:info@orasis-pharma.com)
©2026 Orasis Pharmaceuticals, Inc. All Rights Reserved. QLOSI®, Orasis Pharmaceuticals, the Orasis Pharmaceuticals logo, and certain other trademarks herein are trademarks of Orasis Pharmaceuticals, Inc.
[Privacy Policy](https://orasis-pharma.com/privacy-policy?hsLang=en) [Terms of Service](https://orasis-pharma.com/terms-of-service?hsLang=en) [Health Data Privacy](https://orasis-pharma.com/health-data-privacy-policy?hsLang=en)
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.orasis-pharma.com/#organization",
"@type" : "Organization",
"address" : {
"@type" : "PostalAddress",
"addressCountry" : "US",
"addressLocality" : "Ponte Vedra",
"addressRegion" : "FL",
"postalCode" : "32081",
"streetAddress" : "203 Fort Wade Rd., #140"
},
"contactPoint" : {
"@type" : "ContactPoint",
"contactType" : "customer service",
"email" : "info@orasis-pharma.com",
"telephone" : "+1-866-672-7471"
},
"description" : "Orasis Pharmaceuticals is an ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities, developer of Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% for the treatment of presbyopia in adults.",
"logo" : "https://qlosiecp.com/hubfs/HQ%20Only/Orasis_Pharmaceuticals_Logo_RGB.svg",
"name" : "Orasis Pharmaceuticals",
"sameAs" : [ "https://www.linkedin.com/company/orasis-pharmaceuticals/", "https://twitter.com/OrasisPharma" ],
"url" : "https://www.orasis-pharma.com/"
}
```
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.orasis-pharma.com/#website",
"@type" : "WebSite",
"name" : "Orasis Pharmaceuticals",
"publisher" : {
"@id" : "https://www.orasis-pharma.com/#organization"
},
"url" : "https://www.orasis-pharma.com/"
}
```